Fluzoparib

DB15637InvestigationalSmall molecule

Fluzoparib is under investigation in clinical trial NCT03863860 (A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients).

Formula / weight: C₂₂H₁₆F₄N₆O₂ · 472.404 g/mol (avg)
Also known as: Fuzuloparib
Code names: SHR-3162

Resolves to

Compound

UNIITWF0ML1CK8CAS1358715-18-0ChEMBLCHEMBL3930624

Structure

InChIKeyXJGXCBHXFWBOTN-UHFFFAOYSA-NSMILESFC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN2N=C(N=C2C1)C(F)(F)F

Targets

P09874PARP1

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

97Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Fluzoparib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account